Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism

Technology appraisal guidance
Reference number: TA287
Published: 26 June 2013

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: final appraisal determination document

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: final appraisal determination document

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: final appraisal determination document
19 April 2013
(268.29 Kb 18 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 15 April 2013